Tag : CORRECTING

Latest News

CORRECTING and REPLACING Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2019

Newsemia
GUILFORD, Conn.–(BUSINESS WIRE)–First paragraph, first sentence of release should read: Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for...
Latest News

CORRECTING and REPLACING CAPTION FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival

Newsemia
DETROIT–(BUSINESS WIRE)–Physicians who followed the FDA’s approved protocol for Impella RP use achieved 72% patient survival and 88% native heart recovery. Source link...
Latest News

CORRECTING and REPLACING Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)

Newsemia
SAN FRANCISCO–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24NVTA&src=ctag" target="_blank">$NVTA</a> <a href="https://twitter.com/hashtag/diagnostics?src=hash" target="_blank">#diagnostics</a>–In the headline, and in the first sentence of the release, “(NASDAQ: NVTA)” should instead read “(NYSE: NVTA)”...
Latest News

CORRECTING and REPLACING Vivera Pharmaceuticals Licenses TABMELT®, a Sublingual Pharmaceutical Drug-Delivery System for Cannabidiol (CBD)

Newsemia
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–lt;a href=&quot;https://twitter.com/hashtag/CBD?src=hash&quot; target=&quot;_blank&quot;gt;#CBDlt;/agt;–Vivera Pharmaceuticals, Inc. announces TABMELT® for CBD Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy